Global pharmaceutical raw materials and equipment supplier Medisca recently announced that it has entered into an exclusive partnership with European pharmaceutical distributor SUANFARMA, which will give SUANFARMA exclusive global distribution rights to Thyroid Powder, USP.
According to a press release, Medisca has an existing partnership with Thyroid Powder producer Sichuan Deebio Pharmaceutical Co., Ltd (Deebio).
"The June 2021 partnership with Deebio is a major milestone for the pharmaceutical compounding industry, allowing us to secure and maintain a supply of high-quality Thyroid Powder for the U.S. market," Panagiota Danopoulos, SVP of global strategy and innovation at Medisca said, according to the press release. "As soon as Thyroid Powder came to market, we immediately realized that the demand for the drug was beyond our regular distribution channels to pharmacies. We have the ability to expand supply and make this drug available to a variety of markets, channels and patients around the world. A key ingredient. We will now meet this need through our partnership with SUANFARMA."
Gustavo Adolfo Porras, head of sales, North America at SUANFARMA, said the "high-quality standards, transparency and commitment" between Medisca and Deebio has given SUANFARMA the confidence to choose Medisca has their primary supplier to Thyroid Powder, USP.
Medisca will remain the primary supplier of Thyroid Power, USP to pharmacies.